{
    "componentChunkName": "component---src-templates-blog-post-js",
    "path": "/posts/fe1969ce488d11ec93ec31f03c5e3d3f/",
    "result": {"data":{"allMysqlLists":{"edges":[{"node":{"title":"U.S. lines up deal with Pfizer for COVID-19 treatment pill","status":1,"alt":"","src":"","source":"cbsnews","menu":"us","local_src":"","load_img":"","img_url":"https://cbsnews3.cbsistatic.com/hub/i/r/2021/11/18/a44b3df1-ae05-428b-9296-66dc3eda030f/thumbnail/640x360/a7db411857b34c805cd55b3ea2461448/gettyimages-1232590652.jpg#","href":"https://www.cbsnews.com/news/us-pfizer-deal-covid-19-treatment-pill/","description":"The pharmaceutical giant has asked the federal regulators to authorize the experimental pillâ€‹, called Paxlovid.","country":"us","create_time":"2021-11-18T16:40:47.000Z","content":"[\"The U.S. government will pay drugmaker Pfizer nearly $5.3 billion for 10 million treatment courses of its potential COVID-19 treatment if\\u00a0regulators approve it.\", \"Pfizer asked the Food and Drug Administration on Tuesday to authorize the experimental pill, called Paxlovid.\", \"Earlier this month, the company said Paxlovid cut the risk of\\u00a0hospitalization and death by nearly 90%\\u00a0in people with mild to moderate coronavirus infections. The drugmaker studied its pill in people who were unvaccinated and who faced the greatest risk from the virus due to age or health problems, such as obesity.\", \"The FDA is already reviewing a competing pill from Merck and will hold a public meeting on it later this month.\", \"The price for Pfizer's potential treatment amounts to about $529 per course. The U.S. has already agreed to pay roughly $700 per course of Merck's drug for about 1.7 million treatments.\", \"Pfizer said Thursday the price being paid by the U.S. government reflects the high number of treatment courses purchased through 2022.\", \"Pfizer, which also produces a coronavirus vaccine, earlier on Tuesday announced that it has signed a deal with a U.N.-backed group to allow\\u00a0other manufacturers to make\\u00a0the COVID-19 pill, a move that could make the treatment available to more than half of the world's population.\\u00a0\", \"Meanwhile, the Labor Department's Occupational Safety and Health Administration said it is suspending its enforcement of the\\u00a0Biden administration's new rules\\u00a0ordering larger employers to either require that their workers get vaccinated against\\u00a0COVID-19\\u00a0or undergo weekly testing.\", \"The federal agency said it is complying with a court ruling that temporarily halts the regulation for big employers, according to the OSHA website where the announcement was first\\u00a0posted.\", \"For Breaking News & Analysis Download the Free CBS News app\"]","href_hash":"fe1969ce488d11ec93ec31f03c5e3d3f"}}]}},"pageContext":{"slug":"fe1969ce488d11ec93ec31f03c5e3d3f"}},
    "staticQueryHashes": ["3649515864","764694655"]}